ARGATROBAN Side Effects

7010439-6 | Haemorrhage, Liver Disorder
on Sep 20, 2010 Female patient from UNITED STATES , 85 years of age, weighting 149.9 lb, was treated with Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage, liver disorder. Argatroban dosage: Unk. During the same period patient was treated with FONDAPARINUX (View Fondaparinux Review and Fondaparinux Label ), ACETYLSALICYLIC ACID (81 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL BISULFATE (75 Mg, 1x/day) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ROSUVASTATIN CALCIUM (10 Mg, 1x/day) (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), METOPROLOL SUCCINATE (23.75 Mg, 1x/day) (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

6992028-2 | Aneurysm Ruptured, Retroperitoneal Haematoma
Patient was taking Argatroban (View Usage). Patient had the following side effects: aneurysm ruptured, retroperitoneal haematoma on Sep 06, 2010 from JAPAN Additional patient health information: Male patient , 71 years of age, was diagnosed with embolic stroke, cerebral infarction and. Argatroban dosage: 60 Mg, Daily. During the same period patient was treated with RADICUT (30 Mg, 2x/day) (View Radicut Review and Radicut Label ), WARFARIN POTASSIUM (4 Df, Unk) (View Warfarin Potassium Review and Warfarin Potassium Label ). Patient was hospitalized.

6977204-7 | Pulmonary Embolism
Adverse event was reported on Aug 31, 2010 by a Male patient taking Argatroban (View Usage) (Dosage: 1.6 Ug/kg/min (9.0 Ml/hr)) was diagnosed with heparin-induced thrombocytopenia, hypertension, diabetes mellitus, hypercholesterolaemia, benign prostatic hyperplasia, pain in extremity and. Location: FRANCE , 76 years of age, weighting 205.0 lb, After Argatroban was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with LOSARTAN (50 Once Daily) (View Losartan Review and Losartan Label ), INSULIN (Unk) (View Insulin Review and Insulin Label ), GLIMEPIRIDE (2 Mg, 1x/day) (View Glimepiride Review and Glimepiride Label ), ATORVASTATIN (10 Mg, 1x/day) (View Atorvastatin Review and Atorvastatin Label ), WARFARIN (7 Mg, 1x/day) (View Warfarin Review and Warfarin Label ), PENTOXIFYLLINE (400 Mg, 2x/day) (View Pentoxifylline Review and Pentoxifylline Label ), ALFUZOSIN (10 Mg, 1x/day) (View Alfuzosin Review and Alfuzosin Label ), PREGABALIN (100 Mg, 2x/day) (View Pregabalin Review and Pregabalin Label ).

6962904-5 | Cardiac Arrest, Hypotension, Ventricular Fibrillation
on Aug 26, 2010 Male patient from UNITED STATES , weighting 146.6 lb, was diagnosed with thrombocytopenia, sepsis (What is sepsis?) and was treated with Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), hypotension, ventricular fibrillation. Argatroban dosage: 0.5 To 7.5 Mg/hr. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).


6943379-9 | International Normalised Ratio Increased
on Jul 20, 2010 Male patient from UNITED STATES , 60 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). Patient had the following side effects: international normalised ratio increased. Argatroban dosage: 25 Mcg/kg/min.

6933798-9 | Blue Toe Syndrome, Chest Pain, International Normalised Ratio Increased, Pelvic Venous Thrombosis, Pulmonary Embolism
Patient was taking Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: blue toe syndrome, chest pain (What is chest pain?), international normalised ratio increased, pelvic venous thrombosis, pulmonary embolism (What is pulmonary embolism?) on Aug 09, 2010 from FRANCE Additional patient health information: Male patient , 76 years of age, weighting 205.0 lb, was diagnosed with heparin-induced thrombocytopenia, hypertension, diabetes mellitus, hypercholesterolaemia, benign prostatic hyperplasia, pain in extremity and. Argatroban dosage: 1.6 Ug/kg/min (9.0 Ml/hr). During the same period patient was treated with LOSARTAN (50 Once Daily) (View Losartan Review and Losartan Label ), INSULIN (Unk) (View Insulin Review and Insulin Label ), GLIMEPIRIDE (2 Mg, 1x/day) (View Glimepiride Review and Glimepiride Label ), ATORVASTATIN (10 Mg, 1x/day) (View Atorvastatin Review and Atorvastatin Label ), WARFARIN (7 Mg, 1x/day) (View Warfarin Review and Warfarin Label ), PENTOXIFYLLINE (400 Mg, 2x/day) (View Pentoxifylline Review and Pentoxifylline Label ), ALFUZOSIN (10 Mg, 1x/day) (View Alfuzosin Review and Alfuzosin Label ), PREGABALIN (100 Mg, 2x/day) (View Pregabalin Review and Pregabalin Label ).

6925161-1 | International Normalised Ratio Increased
Adverse event was reported on Aug 11, 2010 by a Male patient taking Argatroban (View Usage) (Dosage: Unk) . Location: UNITED STATES , 61 years of age, Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6920006-8 | Cerebral Artery Embolism
on Jul 30, 2010 Male patient from JAPAN , 72 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). Patient had the following side effects: cerebral artery embolism. Argatroban dosage: Unk.

6916768-6 | Activated Partial Thromboplastin Time Abnormal, Cerebral Haemorrhage, Fibrin D Dimer Increased, Multi-organ Failure, Prothrombin Time Abnormal, Sepsis
on Jul 29, 2010 Female patient from JAPAN , 79 years of age, was diagnosed with heparin-induced thrombocytopenia, continuous haemodiafiltration, prophylaxis and was treated with Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: activated partial thromboplastin time abnormal, cerebral haemorrhage, fibrin d dimer increased, multi-organ failure, prothrombin time abnormal, sepsis (What is sepsis?). Argatroban dosage: 0.008 Mcg/kg/min, Unk. During the same period patient was treated with NAFAMOSTAT (240 Mg, Unk) (View Nafamostat Review and Nafamostat Label ), HEPARIN SODIUM (Unk) (View Heparin Sodium Review and Heparin Sodium Label ), RECOMODULIN (View Recomodulin Review and Recomodulin Label ), ELASPOL (300 Mg, Unk) (View Elaspol Review and Elaspol Label ), MIYARI BACTERIA (3 G, Unk) (View Miyari Bacteria Review and Miyari Bacteria Label ), MARZULENE S (3 G, Unk) (View Marzulene S Review and Marzulene S Label ), MEROPEN (2 G, Unk) (View Meropen Review and Meropen Label ), ANTHROBIN P (1.50 Kiu, Unk) (View Anthrobin P Review and Anthrobin P Label ). Patient was hospitalized and became disabled.

6802007-3 | International Normalised Ratio Increased
Patient was taking Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased on Jun 15, 2007 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 227.0 lb, was diagnosed with heparin-induced thrombocytopenia and. Argatroban dosage: 0.75 Mcg/kg/min,frequency: Unk. During the same period patient was treated with CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (View Fluticasone Propionate, Salmeterol Xinafoate Review and Fluticasone Propionate, Salmeterol Xinafoate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6801988-1 | Haemorrhage
Adverse event was reported on Mar 26, 2003 by a Female patient taking Argatroban (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 6.61 lb, Patient had the following side effects: haemorrhage.

6794188-5 | Coagulation Time Prolonged, Overdose
on Feb 04, 2008 Female patient from UNITED STATES , 63 years of age, weighting 284.9 lb, was diagnosed with pulmonary embolism (What is pulmonary embolism?), heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: coagulation time prolonged, overdose. Argatroban dosage: Frequency: Hr. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), MAALOX (View Maalox Review and Maalox Label ), INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ).

6794182-4 | Coagulation Time Prolonged
on Aug 27, 2008 Female patient from UNITED STATES , 60 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: coagulation time prolonged. Argatroban dosage: 0.7 Mcg/kg/min,frequency: Unk. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), PROPOFOL (View Propofol Review and Propofol Label ).

6794173-3 | Coagulation Time Prolonged
Patient was taking Argatroban (View Usage). Patient had the following side effects: coagulation time prolonged on Oct 08, 2007 from UNITED STATES Additional patient health information: Female patient , 71 years of age, was diagnosed with heparin-induced thrombocytopenia and. Argatroban dosage: 2 Mcg/kg/min,frequency: Unk. Patient was hospitalized.

6794153-8 | Coagulation Time Prolonged
Adverse event was reported on Jul 09, 2008 by a Male patient taking Argatroban (View Usage) (Dosage: Frequency: Unk) was diagnosed with heparin-induced thrombocytopenia and. Location: UNITED STATES , 60 years of age, After Argatroban was administered, patient had the following side effects: coagulation time prolonged. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), MORPHINE (View Morphine Review and Morphine Label ), MIDAZOLAM HYDROCHLORIDE (View Midazolam Hydrochloride Review and Midazolam Hydrochloride Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ).

6794151-4 | Coagulation Time Prolonged
on Mar 13, 2008 Male patient from UNITED STATES , 65 years of age, was treated with Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: coagulation time prolonged. Argatroban dosage: .

6794146-0 | Activated Partial Thromboplastin Time Abnormal
on Apr 07, 2008 Female patient from UNITED STATES , 66 years of age, was diagnosed with heparin-induced thrombocytopenia, thromboembolectomy and was treated with Argatroban (View Usage). Patient had the following side effects: activated partial thromboplastin time abnormal. Argatroban dosage: 2 Mcg/kg/min. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6794145-9 | Coagulation Time Prolonged
Patient was taking Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: coagulation time prolonged on Apr 03, 2008 from UNITED STATES Additional patient health information: Female patient , 81 years of age, was diagnosed with heparin-induced thrombocytopenia and. Argatroban dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6794057-0 | International Normalised Ratio Decreased
Adverse event was reported on Apr 03, 2007 by a Female patient taking Argatroban (View Usage) (Dosage: 2 Mcg/kg/min,frequency: Unk) was diagnosed with heparin-induced thrombocytopenia, heart valve operation and. Location: UNITED STATES , weighting 199.5 lb, Patient experienced the following unwanted or unexpected effects: international normalised ratio decreased. During the same period patient was treated with WARFARIN SODIUM (Frequency: Qd, 5 Days A Week) (View Warfarin Sodium Review and Warfarin Sodium Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6794056-9 | Upper Gastrointestinal Haemorrhage
on Oct 31, 2001 Male patient from UNITED STATES , 29 years of age, was treated with Argatroban (View Usage). Patient had the following side effects: upper gastrointestinal haemorrhage. Argatroban dosage: .

6794054-5 | Coagulation Time Prolonged
on Sep 25, 2007 Female patient from UNITED STATES , 95 years of age, weighting 163.1 lb, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: coagulation time prolonged. Argatroban dosage: 2 Mcg/kg/min,frequency: Unk.

6794049-1 | Urticaria
Patient was taking Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria on Nov 19, 2003 from UNITED STATES Additional patient health information: Male patient , 56 years of age, . Argatroban dosage: . During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), GLUCOVANCE (View Glucovance Review and Glucovance Label ), K DUR (View K-dur Review and K-dur Label ).

6794045-4 | Neuropathy Peripheral
Adverse event was reported on Jun 09, 2004 by a Male patient taking Argatroban (View Usage) (Dosage: ) . Location: UNITED STATES , 66 years of age, Patient had the following side effects: neuropathy peripheral. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), INSULIN (View Insulin Review and Insulin Label ), IPATROPIUM BROMIDE (View Ipatropium Bromide Review and Ipatropium Bromide Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ).

6794035-1 | Activated Partial Thromboplastin Time Prolonged
on Mar 15, 2007 Male patient from UNITED STATES , weighting 167.0 lb, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: activated partial thromboplastin time prolonged. Argatroban dosage: 2 Mg/kg/min. During the same period patient was treated with BISACODYL (View Bisacodyl Review and Bisacodyl Label ).

6794034-X | Coagulation Time Abnormal
on Apr 18, 2007 Female patient from UNITED STATES , 51 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: coagulation time abnormal. Argatroban dosage: Varying Dosages. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), MIDODRINE HYDROCHLORIDE (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ).

6794033-8 | Prothrombin Time Prolonged
Patient was taking Argatroban (View Usage). Patient had the following side effects: prothrombin time prolonged on Jan 29, 2007 from UNITED STATES Additional patient health information: Female patient , 76 years of age, weighting 204.0 lb, was diagnosed with thrombocytopenia and. Argatroban dosage: 2.85 Ml/hr.

6794031-4 | Bradycardia, Cardiac Arrest, Hypotension
Adverse event was reported on Dec 07, 2005 by a Male patient taking Argatroban (View Usage) (Dosage: ) was diagnosed with bradycardia, hypotension, cardiac arrest (What is cardiac arrest?) and. Location: UNITED STATES , 41 years of age, After Argatroban was administered, patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), hypotension. During the same period patient was treated with EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), VASOPRESSIN (View Vasopressin Review and Vasopressin Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6794030-2 | Gastrointestinal Haemorrhage, Incision Site Haemorrhage
on Aug 10, 2007 Male patient from UNITED STATES , weighting 141.1 lb, was diagnosed with heparin-induced thrombocytopenia, coronary artery bypass (What is coronary artery bypass?) and was treated with Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, incision site haemorrhage. Argatroban dosage: . During the same period patient was treated with BIVALIRUDIN (View Bivalirudin Review and Bivalirudin Label ). Patient was hospitalized.

6794027-2 | Haematuria
on May 24, 2007 Female patient from JAPAN , 95 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Argatroban (View Usage). Patient had the following side effects: haematuria. Argatroban dosage: Frequency: Qd.

6794025-9 | Haematocrit Decreased, Haematuria, Haemoglobin Decreased
Patient was taking Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: haematocrit decreased, haematuria, haemoglobin decreased on May 03, 2007 from UNITED STATES Additional patient health information: Male patient , 56 years of age, was diagnosed with heparin-induced thrombocytopenia and. Argatroban dosage: 2 Mcg/kg/min,frequency: Continuous. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), INSULIN (View Insulin Review and Insulin Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).

6794019-3 | International Normalised Ratio Increased
Adverse event was reported on Oct 13, 2006 by a Male patient taking Argatroban (View Usage) (Dosage: ) . Location: UNITED STATES , 70 years of age, weighting 211.6 lb, Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. During the same period patient was treated with VITAMIN C (View Vitamin C Review and Vitamin C Label ), REGULAR INSULIN (View Regular Insulin Review and Regular Insulin Label ), NOVOLOG (View Novolog Review and Novolog Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PROCRIT (View Procrit Review and Procrit Label ), COREG (View Coreg Review and Coreg Label ), IRON (View Iron Review and Iron Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6794009-0 | Haemorrhage Intracranial
on Oct 17, 2006 Female patient from UNITED STATES , 70 years of age, was treated with Argatroban (View Usage). Patient had the following side effects: haemorrhage intracranial. Argatroban dosage: .

6794008-9 | Haemorrhage Subcutaneous
on Jul 06, 2007 Male patient from JAPAN , 50 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: haemorrhage subcutaneous. Argatroban dosage: Frequency: Qd.

6794002-8 | Liver Function Test Abnormal
Patient was taking Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal on Dec 13, 2002 from UNITED STATES Additional patient health information: Female patient , 64 years of age, was diagnosed with diabetes mellitus and. Argatroban dosage: . During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), ACTOS (View Actos Review and Actos Label ).

6794000-4 | Coagulation Time Abnormal
Adverse event was reported on Mar 30, 2007 by a Female patient taking Argatroban (View Usage) (Dosage: 2 Mcg/kg/min,frequency: With Frequenct Titration) was diagnosed with heparin-induced thrombocytopenia, urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , weighting 201.5 lb, Patient had the following side effects: coagulation time abnormal. During the same period patient was treated with LINEZOLID (Frequency: Bid Q12 Hrs) (View Linezolid Review and Linezolid Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ). Patient was hospitalized.

6793995-2 | Injection Site Reaction
on Aug 08, 2006 Female patient from UNITED STATES , 69 years of age, was treated with Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: injection site reaction. Argatroban dosage: .

6793994-0 | Coagulation Time Prolonged
on Jul 16, 2007 Female patient from UNITED STATES , 61 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: coagulation time prolonged. Argatroban dosage: 2 Mcg/kg/min,frequency: Unk. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CASPOFUNGIN ACETATE (View Caspofungin Acetate Review and Caspofungin Acetate Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), EPOETIN ALFA (View Epoetin Alfa Review and Epoetin Alfa Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ).

6793984-8 | Coagulation Time Abnormal, Weight Decreased
Patient was taking Argatroban (View Usage). Patient had the following side effects: coagulation time abnormal, weight decreased on Mar 16, 2007 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 174.2 lb, was diagnosed with heparin-induced thrombocytopenia and. Argatroban dosage: 3.3 Mg/hr,frequency: Continuous.

6793979-4 | Infusion Site Haematoma, Infusion Site Reaction
Adverse event was reported on Mar 21, 2007 by a Male patient taking Argatroban (View Usage) (Dosage: 0.75 Mg/kg/min) was diagnosed with heparin-induced thrombocytopenia and. Location: UNITED STATES , 78 years of age, After Argatroban was administered, patient had the following side effects: infusion site haematoma, infusion site reaction. During the same period patient was treated with METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), VICODIN (View Vicodin Review and Vicodin Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ).

6793976-9 | Coagulation Time Abnormal
on Feb 20, 2007 Male patient from UNITED STATES , weighting 172.0 lb, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: coagulation time abnormal. Argatroban dosage: 78 Ug Per Min. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ).

6793972-1 | Activated Partial Thromboplastin Time Prolonged, International Normalised Ratio Increased
on Jun 14, 2007 Male patient from UNITED STATES , 39 years of age, weighting 220.5 lb, was diagnosed with thrombosis, central venous catheterisation and was treated with Argatroban (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, international normalised ratio increased. Argatroban dosage: 2mcg/kg/min. During the same period patient was treated with HEPARIN (2900 Ut,frequency: Hr) (View Heparin Review and Heparin Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), MICONAZOLE NITRATE (View Miconazole Nitrate Review and Miconazole Nitrate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CHLORINATED SODA SOLUTION (View Chlorinated Soda Solution Review and Chlorinated Soda Solution Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6793967-8 | Coagulation Time Prolonged
Patient was taking Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: coagulation time prolonged on May 14, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 117.5 lb, was diagnosed with heparin-induced thrombocytopenia and. Argatroban dosage: 2 Mcg/kg/min,frequency: Unk. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), TRAZODONE HYDROCHLORIDE (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6793966-6 | Unevaluable Event
Adverse event was reported on Sep 25, 2007 by a Female patient taking Argatroban (View Usage) (Dosage: 0.164 Mcg/kg/min,frequency: Unk) was diagnosed with heparin-induced thrombocytopenia and. Location: UNITED STATES , 80 years of age, weighting 162.5 lb, Patient experienced the following unwanted or unexpected effects: unevaluable event. During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ACETYLCYSTEINE (20 %) (View Acetylcysteine Review and Acetylcysteine Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), BRIMONIDINE (0.15 %) (View Brimonidine Review and Brimonidine Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), DORZOLAMIDE (2 %) (View Dorzolamide Review and Dorzolamide Label ).

6793958-7 | Thrombosis
on Oct 22, 2004 Female patient from UNITED STATES , 22 years of age, was treated with Argatroban (View Usage). Patient had the following side effects: thrombosis. Argatroban dosage: . Patient was hospitalized.

6793957-5 | Coagulation Time Prolonged
on Sep 27, 2007 Female patient from UNITED STATES , 73 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: coagulation time prolonged. Argatroban dosage: 1 Mcg/kg/min,frequency: Unk.

6793951-4 | Catheter Site Haemorrhage
Patient was taking Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: catheter site haemorrhage on Mar 07, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 196.2 lb, was diagnosed with percutaneous coronary intervention and. Argatroban dosage: 25 Mcg/kg/min. During the same period patient was treated with PARICALCITOL (View Paricalcitol Review and Paricalcitol Label ).

6793941-1 | Coagulation Time Prolonged, International Normalised Ratio Increased
Adverse event was reported on Feb 13, 2007 by a Female patient taking Argatroban (View Usage) (Dosage: 2 Mcg/kg/min,frequency: Continuous) was diagnosed with heparin-induced thrombocytopenia and. Location: UNITED STATES , weighting 230.8 lb, Patient had the following side effects: coagulation time prolonged, international normalised ratio increased. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), GUAIFENESIN (View Guaifenesin Review and Guaifenesin Label ), INSULIN (View Insulin Review and Insulin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MIDODRINE HYDROCHLORIDE (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ).

6793938-1 | Haemorrhage, Thrombosis
on Jan 09, 2004 Male patient from UNITED STATES , 63 years of age, was treated with Argatroban (View Usage). After Argatroban was administered, patient had the following side effects: haemorrhage, thrombosis. Argatroban dosage: .

6793937-X | International Normalised Ratio Increased
on Dec 08, 2006 Female patient from UNITED STATES , 66 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. Argatroban dosage: 2 Mcg/kg/min. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DOCUSATE (View Docusate Review and Docusate Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

6793936-8 | Haemorrhage
Patient was taking Argatroban (View Usage). Patient had the following side effects: haemorrhage on Dec 07, 2001 from UNITED STATES Additional patient health information: Male patient , 50 years of age, . Argatroban dosage: . Patient was hospitalized.